Assetmark Inc. Buys 394,813 Shares of Healthpeak Properties, Inc. $DOC

Assetmark Inc. grew its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 8,686.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 399,358 shares of the real estate investment trust’s stock after purchasing an additional 394,813 shares during the period. Assetmark Inc.’s holdings in Healthpeak Properties were worth $7,648,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Mather Group LLC. bought a new stake in Healthpeak Properties in the third quarter worth $25,000. City Holding Co. purchased a new stake in shares of Healthpeak Properties in the third quarter valued at $26,000. Rexford Capital Inc. bought a new stake in shares of Healthpeak Properties in the 2nd quarter worth about $28,000. Sound Income Strategies LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $28,000. Finally, Elevation Point Wealth Partners LLC purchased a new position in shares of Healthpeak Properties during the 2nd quarter worth about $32,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 2.5%

DOC stock opened at $16.70 on Tuesday. The stock has a market capitalization of $11.60 billion, a PE ratio of 166.97, a price-to-earnings-growth ratio of 8.96 and a beta of 1.12. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $21.28. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The firm has a 50 day moving average of $16.79 and a 200 day moving average of $17.55.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million during the quarter, compared to analyst estimates of $685.14 million. During the same quarter last year, the business posted $0.46 EPS. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.3%. Healthpeak Properties’s payout ratio is 1,220.00%.

Analysts Set New Price Targets

DOC has been the subject of several recent analyst reports. Evercore cut their target price on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Robert W. Baird dropped their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. The Goldman Sachs Group assumed coverage on Healthpeak Properties in a research note on Friday, January 9th. They issued a “neutral” rating and a $17.00 target price on the stock. Finally, Weiss Ratings raised shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $19.42.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.